» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 124 | NO. 121 | Tuesday, June 23, 2009

FTC Requests More Info from Merck, Schering-Plough

AP

Print | Front Page | Email this story | Comments ()

NEW YORK (AP) - Drugmakers Merck and Co. and Schering-Plough Corp., which are in the process of a $41.1 billion tie-up, said Monday the Federal Trade Commission has asked for more information about the deal.

Merck, of Whitehouse Station, N.J., and Schering-Plough, Kenilworth, N.J., said they expected the request, which was made under federal antitrust law. The companies intend to cooperate with the request.

Merck agreed to buy Schering-Plough in March, and the companies still expect the deal to close in the fourth quarter. The transaction also requires approval by Merck and Schering-Plough shareholders.

The combined company would be the world's second-largest drugmaker by revenue, with products including the asthma drug Singulair, Nasonex for allergies, and the cholesterol drugs Zetia and Vytorin.

Merck also said Monday it plans to issue about $3.5 billion in debt to fund the Schering-Plough acquisition. Some of the proceeds may also be used for Vioxx lawsuit settlement funds.

In Monday morning trading, Merck shares lost 52 cents, or 2 percent, to $25.39, and Schering-Plough slid 25 cents to $23.55.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 98 312 11,432
MORTGAGES 149 386 14,289
FORECLOSURE NOTICES 0 0 2,278
BUILDING PERMITS 144 693 24,727
BANKRUPTCIES 60 244 8,676
BUSINESS LICENSES 11 93 3,864
UTILITY CONNECTIONS 79 453 13,909
MARRIAGE LICENSES 9 70 3,101

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.